Miranda E. Clements

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis”.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

Cell(2021)10.1016/j.cell.2021.02.048

N/A

0DataRank · unranked

203 citations

Daniel W. Beury, Vishaka Gopalan, Arielle K. Tycko, Haiying Qin, Miranda E. Clements +14 more

Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner

Communications Biology(2021)10.1038/s42003-021-02648-3

N/A

0DataRank · unranked

24 citations

Lawrence A. Vecchi, Miranda E. Clements, Katherine P. Snow, Cayla D. Ontko, Lauren E. Himmel +4 more

HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer

Oncogene(2021)10.1038/s41388-021-01931-1

N/A

0DataRank · unranked

40 citations

Lauren Holtslander, Courtney Edwards, Vera M. Todd, Samuel Dooyema, Kennady K. Bullock +5 more

HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer

Journal of bone oncology(2021)10.1016/j.jbo.2021.100407

N/A

0DataRank · unranked

16 citations

Miranda E. Clements, Lawrence A. Vecchi, Jasmine A. Johnson, Rachelle W. Johnson, Courtney Edwards

Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy

JBMR Plus(2022)10.1002/jbm4.10694

N/A

0DataRank · unranked

8 citations

Lauren Holtslander, Joshua Johnson, Rachelle W. Johnson, Miranda E. Clements